Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution

NCT04284514 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension
Primary Open Angle Glaucoma

Interventions

DRUG: AKB-9778 Ophthalmic Solution
DRUG: Placebo Ophthalmic Solution

Sponsor

Aerpio Therapeutics